PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsReawakening of ancient virus may trigger motor neurone disease

BioNews

Reawakening of ancient virus may trigger motor neurone disease

Published 5 October 2015 posted in News and appears in BioNews 822

Author

Dr Hannah Somers

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Reactivation of an ancient virus embedded in the human genome may trigger the onset of motor neurone disease...

Reactivation of an ancient virus embedded in the human genome may trigger the onset of motor neurone disease (also known as amyotrophic lateral sclerosis or ALS).

Researchers have found that ALS patients with no family history of the disease had higher levels of the ancient retroviral gene HERV-K env than patients with other neurodegenerative diseases, such as Alzheimer's.

Human Endogenous Retroviruses (HERVs) are viruses that integrated themselves into human chromosomes during repeated infections over several million years of human evolution. They make up around eight percent of human DNA, but most have accumulated mutations that render them inactive. Occasionally, however, they can reactivate and cause disease.

In 2006, neurovirologist Dr Avindra Nath of the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, saw a young man who had both HIV, human immunodeficiency virus, and ALS — a degenerative disease that affects the neurons responsible for talking, walking and swallowing, among other motor functions. When the patient started taking antiretroviral drugs to treat his HIV, his ALS symptoms improved.

Following up this intriguing finding, Dr Nath noticed that reverse transcriptase activity (a sign of retrovirus infection) could be seen in ALS patients. 'I reasoned, if you have reverse transcriptase activity and you can't find an exogenous retrovirus, maybe there's an endogenous retrovirus,' said Nath.

Dr Nath and his team inserted either the whole HERV-K genome, or just the env gene, into human neurons in petri dishes. Once the virus (or viral protein) had integrated into the genome of the neuron and activated, it killed significant numbers of neurons.

The researchers also genetically engineered mice to express the virus in their neurons. The mice showed progressively worsening problems with balance and walking before dying prematurely. Analysis of their neurons after they died revealed structural changes associated with degeneration.

The findings, which were published in Science Translational Medicine, suggest that reactivation of the endogenous retrovirus HERV-K can trigger ALS in patients with sporadic (non-inherited) form of the disease.

Dr Nath is now launching a clinical study to see if ALS can be treated with antiretroviral drugs such as those used in the treatment of HIV. 'We haven't proven that the virus causes ALS; we've shown that the virus antiviral product may play a role in the pathophysiology of ALS,' Nath told The Scientist. 'Even if you don't know the cause, if you can find a key molecule in the pathway, you can block it and impact the course of the disease,' he said. 'We think we have a key molecule.'

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 September 2016 • 2 minutes read

Ancient viruses buried in our genomes help to fight off new ones

by Dr Özge Özkaya

Ancient viral DNA could be helping our immune system fight off infections from modern viruses and other pathogens...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
2 August 2016 • 2 minutes read

Ice-bucket challenge funds ALS gene discoveries

by Jenny Sharpe

Donations from the ALS 'ice-bucket challenge' have funded research that has led to the discovery of new genes linked to the disease...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
13 October 2014 • 2 minutes read

FDA fast tracks ALS stem cell therapy

by Rhys Baker

The US Food and Drug Administration (FDA) has awarded 'fast-track' status to a potential stem cell therapy for Amyotrophic Lateral Sclerosis (ALS), or motor neurone disease...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
19 April 2013 • 2 minutes read

Motor neurone disease stem cell trial advances to next phase

by Matthew Young

A neural stem cell therapy aimed at treating the symptoms of amyotrophic lateral sclerosis (ALS) is set to advance in the USA, after the Food and Drug Administration (FDA) gave its approval for it to proceed to the next stage of clinical trials...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
20 February 2013 • 2 minutes read

Positive results in motor neurone disease stem cell safety trial

by Dr Linda Wijlaars

A clinical trial to test the safety of a stem cell treatment for amyotrophic lateral sclerosis, the most common form of motor neurone disease, suggests that the new therapy is safe and well-tolerated. Encouragingly, one of the 12 patients participating in the study showed some improvement, although the trial was not designed to test the treatment's efficacy...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
4 January 2013 • 2 minutes read

Stem cell success against motor neurone disease in mice

by Dr Tamara Hirsch

Neural stem cells were shown to be effective against amyotrophic lateral sclerosis (ALS), or motor neurone disease, in 11 independent studies on mice with the disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 November 2012 • 3 minutes read

Same genetic mutation linked to ALS and dementia

by George Frodsham

Researchers have identified a strong link between a genetic fault and two common neurological disorders. Two independent studies have found that the mutation is common in patients with amyotrophic lateral sclerosis (ALS) and patients with frontotemporal dementia (FTD), particularly if the disease is familial...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Largest catalogue of human genomic variation published

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856